LivaNova (LIVN) Consolidated Net Income (2014 - 2026)
LivaNova's (LIVN) quarterly Consolidated Net Income came in at $108.7 million in Q2 2026, up 300.03% year-over-year from $27.2 million in Q2 2025, and up 369.57% quarter-over-quarter from $23.1 million in Q1 2026.
Analysis
LivaNova (LIVN) Consolidated Net Income (2014 - 2026) Analysis & Trends
LivaNova has disclosed Consolidated Net Income across 13 years of filings, most recently posting $108.7 million for Q2 2026.
- In Q2 2026, Consolidated Net Income rose 300.03% year-over-year to $108.7 million; the TTM figure through Jun 2026 stood at $189.5 million (up 189.69% YoY), while the FY2025 annual figure was -$242.4 million, down 483.26% from the prior year.
- Consolidated Net Income came in at $108.7 million for Q2 2026 at LivaNova, up from $23.1 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $108.7 million in Q2 2026 to a low of -$327.3 million in Q1 2025.
- Average Consolidated Net Income over 5 years is -$6.4 million, with a median of $16.4 million recorded in 2023.
- Year-over-year, Consolidated Net Income soared 1283.09% in 2024 and sank 680.83% in 2025.
- Over 5 years, Consolidated Net Income stood at $1.7 million in 2022, then surged by 867.81% to $16.4 million in 2023, then surged by 241.72% to $55.9 million in 2024, then tumbled by 44.69% to $30.9 million in 2025, then soared by 251.54% to $108.7 million in 2026.
- Per Business Quant data, the three most recent Consolidated Net Income figures were $108.7 million in Q2 2026, $23.1 million in Q1 2026, and $30.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 108.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.68 Mn |
| Mar 31, 2026 | 23.15 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 27.17 Mn |
| Mar 31, 2025 | -327.30 Mn |
| Dec 31, 2024 | 55.89 Mn |
| Sep 30, 2024 | 32.92 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | -41.92 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | -107.40 Mn |
| Jun 30, 2022 | 16.49 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | -5.09 Mn |
| Sep 30, 2021 | -43.42 Mn |